C Bartholomew L Eastlake P Dunn D Yiannakis
10.1016/j.rmcr.2017.01.016
Respir Med Case Rep
2017 Feb 4;20:137-140.
acquired t790m mutation egfr erlotinib (tarceva) non-small cell lung cancer osimertinib (tagrisso) tyrosine kinase inhibitors (tki)
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28217439/
Case Reports
PMC5302182
28217439
EGFR targeted therapy in lung cancer; an evolving story
2017